Trials Aim to Treat Bladder Cancer Without Bladder Removal
Dr. Scot Niglio, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, aims to avoid bladder removal in people with bladder cancer.
A New Weight Loss Surgery Keeps the Pounds Off for Good
NYU Langone’s Dr. Fareed Cheema performs the SADI-S, a weight loss procedure ideal for patients whose previous surgical intervention has failed.
COVID-19 Risk Not Higher for People with Lupus or Arthritis
Two new studies by NYU Langone Health rheumatologists pay close attention to potential COVID-19 risks for patients with preexisting conditions.
‘Bullying’ Intent Sourced in Brains of Mice
NYU Langone study ties warning signs of premeditated violence, such as stalking and bullying, to a distinct part of the brain.
A $1.2 Million Grant Fuels Research Efforts to Humanize AI
NYU Langone researchers Dr. Biyu J. He and Dr. Eric K. Oermann are merging their expertise to build an AI model that imitates the human brain.
A Solid Game Plan Ensures Calm Amid the COVID-19 Storm
Thanks to a strategy adopted weeks before the first wave of COVID-19 hit New York, NYU Langone has stayed ahead of the epidemiological curve.
An Over-the-Counter Continuous Glucose Monitor Debuts
NYU Langone endocrinologist Dr. Michael Natter weighs the pros and cons of the first FDA-approved continuous glucose monitor available over the counter.
Caring for Cancer Patients Who Develop Cardiac Complications
NYU Langone’s new multidisciplinary Cardio-Oncology Program detects, monitors, and treats cardiovascular disease caused by cancer treatments.
Coal-Burning Toxins Linked to Greater Heart Disease Risk
NYU Langone study finds exposure to particles found in fossil fuel emissions is associated with an increased risk of death from heart disease.
Drug Targets Folate Receptor in Ovarian Cancer
A clinical trial at NYU Langone’s Perlmutter Cancer Center is testing a highly selective drug for people with platinum-sensitive ovarian cancer.